Study guide
7.1 Re-Evaluation Domain and Decision Cycle
Wound Care Certified WCC
Track your progress as you read
Finished sections get a check mark.
1 Orientation: NAWCO WCC Exam, Eligibility, and Scoring
1.1 Credential Purpose, Sponsor, and Scope 1.2 Qualifying License and Eligibility Frame 1.3 Education and Experience Pathways 1.4 Exam Format, Delivery, and Timing 1.5 Scoring, Standard Setting, and Confidentiality 1.6 Fees, Scheduling, Retesting, and Recertification
2 Wound Assessment: Etiology, Status, and Skin Integrity
2.1 Assessment Domain and Exam Approach 2.2 Etiology Patterns and Location Clues 2.3 Wound Status: Measurement, Tissue, and Exudate 2.4 Depth, Tissue Loss, and Pressure Injury Language 2.5 Skin Structure, Function, and Barrier 2.6 Skin Integrity Across the Lifespan
3 Patient Assessment: Labs, Nutrition, Pain, and Risk Tools
3.1 Labs and Diagnostic Data in Wound Assessment 3.2 Nutrition, Hydration, and Healing Risk 3.3 Comorbidities, Medications, and Current Condition 3.4 Psychosocial History, Adherence Barriers, and Access 3.5 Pain Assessment Tools and Treatment Tolerance 3.6 Risk Tools, Cognition, Function, and ADLs
4 Treatment Foundations, Dressings, and Wound Bed Preparation
4.1 Cleansing, Wound Hygiene, and Assessment Before Treatment 4.2 Moisture Balance and Core Dressing Functions 4.3 Dressing Categories, Formulary, and Resource Fit 4.4 Periwound Protection, Exudate, and Securement 4.5 Wound Bed Preparation and Debridement Concepts 4.6 Infection Signs, Prevention, and Escalation
5 Advanced Therapies, Diagnostics, Support Surfaces, and Referrals
5.1 Negative Pressure Wound Therapy Readiness and Monitoring 5.2 Electrical Stimulation, Ultrasound, and Topical Adjuncts 5.3 Diagnostics, Cultures, Labs, and Referral Triggers 5.4 Support Surfaces, Pressure Redistribution, and Microclimate 5.5 Offloading, Compression, and Lymphedema Decision-Making 5.6 Hyperbaric Oxygen and Specialty Referral Coordination
6 Infection, Vascular, Diabetic, and Pressure Injury Scenarios
6.1 Local, Spreading, and Systemic Infection Signals 6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps 6.3 Diabetic Foot Ulcer Scenarios: Neuropathy, Perfusion, and Offloading 6.4 Venous, Arterial, and Mixed Vascular Wound Scenarios 6.5 Pressure Injury Prevention, Staging, and Treatment Scenarios 6.6 Integrated Contraindication and Priority Scenarios
7 Reevaluation, Healing Progression, and Treatment Adjustment
7.1 Re-Evaluation Domain and Decision Cycle 7.2 Treatment Choice and Plan Effectiveness 7.3 Weekly Measurement and Trend Monitoring 7.4 Tolerance, Pain, and Treatment Reactions 7.5 Adherence Barriers and Plan Adjustment 7.6 Healing Phases and Progression Decisions
8 Education, Health Literacy, and Interprofessional Teaching
8.1 Education Domain Scope and Priorities 8.2 Patient and Family Treatment-Plan Teaching 8.3 Health Literacy, Plain Language, and Teach-Back 8.4 Language, Cognition, Sensory Needs, and Cultural Adaptation 8.5 Discharge Teaching and Home Adherence 8.6 Interprofessional Team Teaching and Prevention Reinforcement
9 Administration, Protocols, Data Quality, and Care Coordination
9.1 Administration Domain Map for WCC Candidates 9.2 Evidence-Based Protocols and Facility Processes 9.3 Formularies, Product Access, and Treatment-Plan Workflow 9.4 Educational Media and Team Communication Tools 9.5 Data Quality, Prevalence, Incidence, and Outcome Monitoring 9.6 Payers, Case Management, and Transition Coordination
10 Legal Documentation, Ethics, Scope, and Patient Autonomy
10.1 Legal Domain Map for WCC Candidates 10.2 Objective Wound-Characteristic Documentation 10.3 Treatment-Plan Documentation and Continuity 10.4 Scope of Practice, Regulatory Issues, and Consultation 10.5 Ethics, Culture, Palliative Care, and Patient Autonomy 10.6 Confidentiality, Record Integrity, and Exam Conduct
11 Risk, Prevention, At-Risk Populations, and Product Selection
11.1 Risk Framework for Impaired Skin Integrity 11.2 Pressure Prevention, Repositioning, and Support Surfaces 11.3 Moisture, Incontinence, and Periwound Protection 11.4 Offloading, Foot Risk, and At-Risk Populations 11.5 Product Indications, Contraindications, and Selection 11.6 Population-Specific Prevention Across Settings
12 Integrated WCC Case Scenarios and Final Review
12.1 Blueprint-Weighted Final Review Strategy 12.2 Integrated Pressure Injury Case Review 12.3 Integrated Diabetic Foot and Vascular Case Review 12.4 Integrated Venous Leg Ulcer and Compression Case Review 12.5 Legal, Education, and Administration Integrated Cases 12.6 Exam Day, Scoring, Retake, and Recertification Review
7.1 Re-Evaluation Domain and Decision Cycle
Key Takeaways Explain This Topic AI
Re-Evaluation is an official WCC blueprint domain weighted at 16 percent, the third-largest after Assessment (27 percent) and Treatment (25 percent).
Reevaluation is a repeating cycle that compares baseline, prior visit, and current findings against the stated wound goal before acting.
The WCC exam rewards criterion-based reasoning, not reflexive product changes after a single measurement or one unchanged week.
Certification does not expand state scope of practice or employer policy authority; the state board and employer govern what the certificant may do.
Last updated: June 2026
Re-Evaluation as a Repeatable Decision Cycle
The National Alliance of Wound Care and Ostomy (NAWCO) blueprint, administered by the National Alliance of Wound Care and Ostomy Certification Board, lists Re-Evaluation as 16 percent of the Wound Care Certified (WCC) exam. The full 120-item test (110 scored, 10 unscored pretest) runs 2 hours, scores on a scaled range of 100 to 800, and requires a scaled 600 to pass . With 110 scored items, 16 percent is roughly 18 questions, so this domain alone can decide a borderline result.
Re-Evaluation is not a one-time bedside event after treatment ends. It is the repeated comparison of wound status, patient response, adherence, barriers, and treatment goals. A WCC-style reevaluation item typically gives a wound description from last week, a current description, a dressing order, pain or drainage data, and a patient-behavior clue. The task is to decide whether the plan remains effective, needs reinforcement, needs a referral, or needs a change within professional scope and facility process.
The Four-Step Reevaluation Sequence
Use the same sequence on test day every time:
Identify the wound goal (close, stabilize, or palliate for comfort).
Compare current findings to prior findings and to the original baseline.
Attribute the result to wound biology, product performance, tolerance, adherence, or a new risk.
Choose the least assumptive next step that protects the patient and stays within scope.
- Reevaluation cue Exam meaning Safer response
- Smaller wound, healthier tissue, less exudate Plan is likely effective Continue and monitor
- More pain, odor, erythema, purulence, or systemic signs Possible complication Escalate or refer per protocol
- No size change but better tissue quality Partial progress Reassess barriers before switching products
- Product used incorrectly Education or adherence issue Teach and verify technique
- Treatment outside scope or policy Authority problem Collaborate with an authorized clinician
- Applied Scenarios
A patient with a venous leg ulcer returns after one week. The wound is slightly smaller, drainage is moderate rather than heavy, and the patient reports the compression wrap felt snug but tolerable. The WCC answer is not to jump to an advanced therapy just because the ulcer is still open. The better answer continues the effective plan, monitors skin and circulation, reinforces leg elevation and compression, and follows facility policy.
A different item shows a pressure injury with increasing undermining, new malodor, and higher pain during dressing removal. Those findings do not prove a single diagnosis on the exam, but they do show the plan is not safely meeting the goal. The WCC response is to reassess the wound, document and communicate findings, and seek provider or interprofessional review rather than simply adding a more absorbent dressing.
Common Traps
Product shopping. Do not change dressings reflexively. A dressing can be correct for exudate level yet wrong for the patient if it traumatizes tissue, is not used as ordered, conflicts with offloading, or is off-formulary.
Imagined authority. Certification creates no independent prescriptive power. NAWCO states WCC scope is governed by the professional's state regulatory board and employer guidelines.
Single-data-point reasoning. One measurement is noise; trend across visits is signal.
Keep the cycle practical: compare to baseline and last visit, look for trend not one number, link treatment choice to etiology and goal, check pain and tolerance, identify access barriers, and escalate concerns through the team. The WCC exam is criterion-referenced — the passing standard reflects judgments about minimally qualified practice, not a curve. The correct option usually uses wound evidence, respects scope, and avoids a premature treatment jump.
How Reevaluation Items Are Written
Most Re-Evaluation questions are application-level, not recall. The stem describes a clinical situation and asks for the next or best action. Because four plausible options are offered, the exam is really testing which step is the most defensible — the one that gathers needed data, protects the patient, and stays in scope. When two answers both seem reasonable, prefer the one that is least invasive and most reversible and that does not assume a diagnosis the data have not established. A referral or reassessment is rarely wrong on a deteriorating wound; an unsupported product escalation frequently is.
The interval between reevaluations is itself a judgment. Acute postoperative wounds may be reassessed at each dressing change, whereas a stable chronic wound is commonly reviewed weekly so that a meaningful trend can emerge. Reassessing too often invites overreaction to normal day-to-day variation; reassessing too rarely lets a stalled or infected wound progress unchecked. A reasonable cadence for chronic wounds is a comprehensive reevaluation at least weekly, with an immediate reassessment any time a concerning change — fever, spreading erythema, new necrosis, sudden pain, or heavy new bleeding — is reported between scheduled visits.
Reevaluation also closes the documentation loop. Each cycle should record the measurements, tissue and exudate description, pain and tolerance, adherence and barriers, the clinical reasoning, the action taken, and the communication that followed. Strong documentation is what lets the next clinician compare apples to apples — and on the exam, the option that preserves that continuity (consistent technique, complete charting, team communication) is usually the better answer than one that acts on a single impression.
Reevaluation, in short, is the engine that keeps the whole plan honest: it ties Assessment data forward into Treatment decisions and feeds Education and Administration back into the patient's real-world setting.